DEBATE: Biosimilar Therapies - Caution, more studies are needed

What's Health Canada Saying about Biosimilars?Подробнее

Global developments that affect biosimilar medicines - Karsten Roth, Mundipharma BiologicsПодробнее

WEBINAR: Biologics & BiosimilarsПодробнее

DEBATE: Biosimilar Therapies - Use as indicated, in place of our current biologicsПодробнее

IBD: Switching from a Biologic to a BiosimilarПодробнее

Euronews Debates Highlights | How can Europe shape the future of biosimilar medicines?Подробнее

Biosimilars Debate ProПодробнее

What are Biosimilar Therapies and Why Should We Care?Подробнее

Biosimilars and Oncology Clinical Pathways: Perfect TogetherПодробнее

Biologics & Biosimilars: Insights for Patients & PhysiciansПодробнее

Arthritis Consumer Experts' Biosimilars in Canada WebinarПодробнее

Pinpointing the Top Questions and Considerations about Biosimilars in GastroenterologyПодробнее

Beyond Reference Biologics: Biosimilars on the HorizonПодробнее

Biologic or Biosimilar in IBD. It doesn’t matter which.Подробнее

BiosimilarsПодробнее

Biosimilars vs. Interchangeable Biosimilars: What’s the Difference?Подробнее

Biosimilars in IBD: Where Do We Stand Today?Подробнее